ÂÜÀòÂÒÂ×

Jesse L. Carlin, Ph.D., is a seasoned professional in the field of clinical development, currently serving as Director of Clinical Development at Vanda Pharmaceuticals since August 2017, where responsibilities include leading clinical projects and scientific initiatives. Previously, Jesse held a postdoctoral position at the National Institutes of Health, focusing on the pharmacokinetics of neuroprotective compounds and the development of therapeutic assays for obesity and diabetes. Jesse earned a Ph.D. in Pharmacology from the University of Pennsylvania, where research involved oxidative stress and protein dynamics in Alzheimer's models, alongside experience in clinical trial coordination. Jesse also has a background as a professional track athlete with accolades at the national level and has contributed to clinical research and data management in weight and eating disorders.